3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
70
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Stomach Neoplasms
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma
1
Esophageal Neoplasms
1
DMMR Colorectal Cancer
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Abdominal Neoplasms
1
Interventions
pembrolizumab
6
belinostat
2
Pemetrexed
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
tocilizumab
1
sargramostim
1
ribociclib
1
rebastinib
1
enzalutamide
1
entinostat
1
durvalumab
1
cemiplimab
1
avelumab
1
atezolizumab
1
abemaciclib
1
Valacyclovir
1
Surgical Procedures, Operative
1
Sorafenib
1
Sirolimus
1
Quality of Life
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Plicamycin
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Midazolam
1
Microarray Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Surgical Procedures, Operative
×
Other solid neoplasm
×
Clear all
NCT06281860
2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1
Unknown
39 enrolled